newsfilter
← Latest News
GlobeNewswire·

Kinnate Biopharma Inc. to Participate in the 2022 Wells Fargo Securities Healthcare Conference

SAN FRANCISCO and SAN DIEGO, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (NASDAQ:KNTE) ("Kinnate"), a clinical-stage precision oncology company, today announced that its chief executive officer, Nima Farzan, will participate in a fireside